Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Endo International : Citigroup Adjusts Price Target on Endo International to $11 From $10, Maintains Buy Rating

05/17/2021 | 11:17am EDT


© MT Newswires 2021
All news about ENDO INTERNATIONAL PLC
07/22ENDO INTERNATIONAL : Reaches Agreement in Principle to Settle Opioid-Related Cas..
MT
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Announces Agreement in Principle to Settle Tennessee State ..
AQ
07/21FACTBOX-Companies pay billions of dollars over role in U.S. opioid crisis
RE
07/21Drugmakers, pharmacies next targets for U.S. opioid settlements
RE
07/20New York, drug distributors reach $1.18 billion opioid settlement as national..
RE
07/20MARKET CHATTER : Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes..
MT
07/20SECTOR UPDATE : Health Care Stock Drifting Away From Earlier Highs This Afternoo..
MT
07/20Endo international shares last up 31% at $4.40 in heavy volume
RE
More news
Financials (USD)
Sales 2021 2 725 M - -
Net income 2021 122 M - -
Net Debt 2021 6 743 M - -
P/E ratio 2021 7,94x
Yield 2021 -
Capitalization 1 167 M 1 167 M -
EV / Sales 2021 2,90x
EV / Sales 2022 2,80x
Nbr of Employees 3 397
Free-Float 98,5%
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 5,00 $
Average target price 7,78 $
Spread / Average Target 55,6%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
Robert Polke Global Head-Operations